Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC
Clinical trial NCT06508229 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06508229
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2027-05-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.